Suppr超能文献

α-突触核蛋白缺陷小鼠对毒素诱导的多系统萎缩具有抗性。

Alpha-synuclein deficient mice are resistant to toxin-induced multiple system atrophy.

作者信息

Ubhi Kiren, Rockenstein Edward, Mante Michael, Inglis Chandra, Adame Anthony, Patrick Christina, Masliah Eliezer

机构信息

Department of Neurosciences, University of California San Diego, School of Medicine, La Jolla, California 92093-0624, USA.

出版信息

Neuroreport. 2010 Apr 21;21(6):457-62. doi: 10.1097/WNR.0b013e328338ba6b.

Abstract

Multiple systems atrophy (MSA) is a neurodegenerative disorder characterized by oligodendrocytic accumulations of alpha-synuclein (alphasyn). Oxidative stress is a key mechanism proposed to underlie MSA pathology. To address the role of alphasyn modifications, over and above general oxidative modifications, this study examined the effects of 3-nitropropionic acid (3NP) administration, a technique used to model MSA, in knock-out mice lacking alphasyn (alphasynKO). Although susceptible to 3NP-induced oxidative stress, alphasynKO mice display reduced neuronal loss and dendritic pathology. The alphasynKO mice are resistant to 3NP-induced motor deficits and display attenuated loss of tyrosine hydroxylase and dopamine transporter striatal immunoreactivity. The results suggest that deficits in MSA are not due to general oxidative protein modification but in addition may be related to specific alphasyn modifications.

摘要

多系统萎缩(MSA)是一种神经退行性疾病,其特征是α-突触核蛋白(α-syn)在少突胶质细胞中积聚。氧化应激是被认为是MSA病理学基础的关键机制。为了研究α-syn修饰的作用,除了一般的氧化修饰之外,本研究检测了给予3-硝基丙酸(3NP)(一种用于模拟MSA的技术)对缺乏α-syn的基因敲除小鼠(α-synKO)的影响。尽管α-synKO小鼠易受3NP诱导的氧化应激影响,但它们的神经元损失和树突病理表现有所减轻。α-synKO小鼠对3NP诱导的运动缺陷具有抗性,并且酪氨酸羟化酶和多巴胺转运体纹状体免疫反应性的损失减弱。结果表明,MSA的缺陷并非由于一般的氧化蛋白质修饰,此外可能还与特定的α-syn修饰有关。

相似文献

1
Alpha-synuclein deficient mice are resistant to toxin-induced multiple system atrophy.
Neuroreport. 2010 Apr 21;21(6):457-62. doi: 10.1097/WNR.0b013e328338ba6b.
5
Erythropoietin is neuroprotective in a transgenic mouse model of multiple system atrophy.
Mov Disord. 2011 Feb 15;26(3):507-515. doi: 10.1002/mds.23474. Epub 2011 Jan 6.
6
Neuroprotection by Epigenetic Modulation in a Transgenic Model of Multiple System Atrophy.
Neurotherapeutics. 2016 Oct;13(4):871-879. doi: 10.1007/s13311-016-0447-1.
7
α-Synuclein-induced myelination deficit defines a novel interventional target for multiple system atrophy.
Acta Neuropathol. 2016 Jul;132(1):59-75. doi: 10.1007/s00401-016-1572-y. Epub 2016 Apr 8.
8
Alpha-synuclein transgenic mice: relevance to multiple system atrophy.
Mov Disord. 2005 Aug;20 Suppl 12:S64-6. doi: 10.1002/mds.20542.
9
Rasagiline is neuroprotective in a transgenic model of multiple system atrophy.
Exp Neurol. 2008 Apr;210(2):421-7. doi: 10.1016/j.expneurol.2007.11.022. Epub 2007 Dec 4.

引用本文的文献

2
Multiple system atrophy: pathogenic mechanisms and biomarkers.
J Neural Transm (Vienna). 2016 Jun;123(6):555-72. doi: 10.1007/s00702-016-1545-2. Epub 2016 Apr 20.
3
Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders?
Mol Neurobiol. 2016 Jul;53(5):3046-3062. doi: 10.1007/s12035-015-9205-3. Epub 2015 May 13.
4
A novel triple repeat mutant tau transgenic model that mimics aspects of pick's disease and fronto-temporal tauopathies.
PLoS One. 2015 Mar 24;10(3):e0121570. doi: 10.1371/journal.pone.0121570. eCollection 2015.
5
LIMP-2 expression is critical for β-glucocerebrosidase activity and α-synuclein clearance.
Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15573-8. doi: 10.1073/pnas.1405700111. Epub 2014 Oct 14.
6
Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo.
Brain. 2014 May;137(Pt 5):1496-513. doi: 10.1093/brain/awu057. Epub 2014 Mar 24.
7
Towards translational therapies for multiple system atrophy.
Prog Neurobiol. 2014 Jul;118:19-35. doi: 10.1016/j.pneurobio.2014.02.007. Epub 2014 Mar 2.
8
Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection.
Ther Adv Neurol Disord. 2011 Sep;4(5):297-317. doi: 10.1177/1756285611406166.
9
Multiple system atrophy: a clinical and neuropathological perspective.
Trends Neurosci. 2011 Nov;34(11):581-90. doi: 10.1016/j.tins.2011.08.003. Epub 2011 Sep 29.
10
Multiple system atrophy: current and future approaches to management.
Ther Adv Neurol Disord. 2010 Jul;3(4):249-63. doi: 10.1177/1756285610375328.

本文引用的文献

2
The effect of alpha-synuclein knockdown on MPP+ toxicity in models of human neurons.
Eur J Neurosci. 2008 Dec;28(12):2459-73. doi: 10.1111/j.1460-9568.2008.06527.x. Epub 2008 Nov 21.
3
Rifampicin reduces alpha-synuclein in a transgenic mouse model of multiple system atrophy.
Neuroreport. 2008 Aug 27;19(13):1271-6. doi: 10.1097/WNR.0b013e32830b3661.
4
Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice.
Exp Neurol. 2008 Mar;210(1):182-93. doi: 10.1016/j.expneurol.2007.10.012. Epub 2007 Nov 1.
5
Mice lacking alpha-synuclein are resistant to mitochondrial toxins.
Neurobiol Dis. 2006 Mar;21(3):541-8. doi: 10.1016/j.nbd.2005.08.018. Epub 2005 Nov 18.
8
Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein.
J Neurosci. 2004 Oct 20;24(42):9434-40. doi: 10.1523/JNEUROSCI.3080-04.2004.
9
Case-control study of multiple system atrophy.
Mov Disord. 2005 Feb;20(2):158-63. doi: 10.1002/mds.20303.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验